SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000903423-16-001076
Filing Date
2016-06-02
Accepted
2016-06-02 16:35:45
Documents
4

Document Format Files

Seq Description Document Type Size
1 wildcat13da5.htm SC 13D/A 146618
2 exhibit9_0601.htm EX-9 14040
3 GRAPHIC image_005.gif GRAPHIC 2555
4 GRAPHIC image_004.gif GRAPHIC 1485
  Complete submission text file 0000903423-16-001076.txt   167917
Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Subject) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82540 | Film No.: 161692947
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 888 SEVENTH AVENUE NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE NEW YORK NY 10106 212-468-5100
Wildcat Capital Management, LLC (Filed by) CIK: 0001582384 (see all company filings)

IRS No.: 453715536 | State of Incorp.: DE | Fiscal Year End: 1213
Type: SC 13D/A